Gilead Sciences said Wednesday it will invest $11 billion in U.S. research and manufacturing in the coming years, joining ...

The new investments, unveiled on Wednesday, will supplement an already planned spending of $21 billion to boost U.S.

Shares of Gilead Sciences Inc. GILD rose 1.04% to $98.90 Wednesday, on what proved to be an all-around great trading session ...

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we ...

Gilead Sciences announced $11 billion in new planned investment in the U.S. to boost its domestic manufacturing and research ...

After six chilling seasons, The Handmaid’s Tale is coming to an end, with star Yvonne Strahovski promising a powerful conclusion.

The new plans are in addition to $21B that the drug manufacturer has already committed to U.S. research, development and ...

The company added to a recent flurry of pledges by pharmaceutical companies, promising $11 billion in new capital and ...

Another Big Pharma is opening up its wallet to pour billions into its U.S. operations amid political pressure from the Trump ...

Gilead Sciences adds $11B to its U.S. investment plan, boosting manufacturing, R&D, and job creation. Read more here.

Interim results from the ongoing Phase III ASSURE trial demonstrated that Livdelzi maintained a consistent biochemical ...

Gilead Sciences has joined the list of pharma groups hiking their capital investment plans in the US, adding $11 billion in ...